Dermatology News

The use of biologic medications for autoimmune diseases prior to or during pregnancy is not associated with an increased risk for preterm delivery or infants that are small for gestational age, according to findings published in the Annals of the Rheumatic Diseases.

There was significant discrepancy between patient-reported full-body skin exams, physician reports of these exams, and documentation of the exams in patient charts, according to study findings presented at the American Academy of Dermatology annual meeting.

The American College of Rheumatology has joined eight other national physician groups in calling on HHS to reconsider a series of new drug pricing proposals, including one that would consolidate some medications covered under Medicare Part B into Medicare Part D, warning they could increase costs and limit access for patients.

A 300-mg dose of Dupixent weekly or every 2 weeks significantly improved peak itch scores among patient with moderate-to-severe atopic dermatitis, according to research presented at the American Academy of Dermatology annual meeting.

FDA Commissioner Scott Gottlieb, MD, on Wednesday took aim at the current rebate contracting system for being “rigged against” biosimilar makers, resulting in a payment scheme that decreases market competition and restricts biosimilar uptake and development.

Despite the expedited pathway for biosimilars enacted by the Biologics Price Competition and Innovation Act of 2009, the development of competition in the U.S. biologics market has been slower than expected due to several regulatory issues, according to a new perspective piece published in the New England Journal of Medicine.

The FDA recently approved expanded use of Luzu cream for patients aged 12 years and older with interdigital tinea pedis and tinea cruris and for patients aged 2 years and older with tinea corporis, caused by the organisms Trichophyton rubrum and Epipdermophyton floccosum, according to Ortho Dermatologics.

Among human leukocyte antigen genes, the allele HLA-B*27 correlated with more severe enthesitis among patients with psoriatic arthritis, which suggests that genetic variants can affect an individual’s predisposition to sub-phenotypes of psoriatic arthritis.

Patients with acne were at significant risk for clinical depression, according to data recently appearing in the British Journal of Dermatology.

Three-year treatment with ixekizumab demonstrated high, and sustained, levels of skin clearance in patients with moderate to severe plaque psoriasis, according to findings from the UNCOVER-3 trial presented at the American Academy of Dermatology Annual Meeting.